236 related articles for article (PubMed ID: 33937253)
1. Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma.
Le Joncour V; Guichet PO; Dembélé KP; Mutel A; Campisi D; Perzo N; Desrues L; Modzelewski R; Couraud PO; Honnorat J; Ferracci FX; Marguet F; Laquerrière A; Vera P; Bohn P; Langlois O; Morin F; Gandolfo P; Castel H
Front Cell Dev Biol; 2021; 9():652544. PubMed ID: 33937253
[TBL] [Abstract][Full Text] [Related]
2. Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma.
Lecointre C; Desrues L; Joubert JE; Perzo N; Guichet PO; Le Joncour V; Brulé C; Chabbert M; Leduc R; Prézeau L; Laquerrière A; Proust F; Gandolfo P; Morin F; Castel H
Oncogene; 2015 Sep; 34(39):5080-94. PubMed ID: 25597409
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.
Hirose T; Takahashi K; Mori N; Nakayama T; Kikuya M; Ohkubo T; Kohzuki M; Totsune K; Imai Y
Peptides; 2009 Jun; 30(6):1124-9. PubMed ID: 19463745
[TBL] [Abstract][Full Text] [Related]
4. Association between vasoactive peptide urotensin II in plasma and cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a potential therapeutic target.
Clavier T; Mutel A; Desrues L; Lefevre-Scelles A; Gastaldi G; El Amki M; Dubois M; Melot A; Wurtz V; Curey S; Gérardin E; Proust F; Compère V; Castel H
J Neurosurg; 2018 Oct; 131(4):1278-1288. PubMed ID: 30497195
[TBL] [Abstract][Full Text] [Related]
5. The Urotensin II System and Carotid Atherosclerosis: A Role in Vascular Calcification.
Albanese I; Daskalopoulou SS; Yu B; You Z; Genest J; Alsheikh-Ali A; Schwertani AG
Front Pharmacol; 2016; 7():149. PubMed ID: 27375483
[TBL] [Abstract][Full Text] [Related]
6. Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis.
Kristof AS; You Z; Han YS; Giaid A
Peptides; 2010 Aug; 31(8):1511-6. PubMed ID: 20433884
[TBL] [Abstract][Full Text] [Related]
7. Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro.
Spinazzi R; Albertin G; Nico B; Guidolin D; Di Liddo R; Rossi GP; Ribatti D; Nussdorfer GG
Int J Mol Med; 2006 Dec; 18(6):1107-12. PubMed ID: 17089015
[TBL] [Abstract][Full Text] [Related]
8. Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.
Dubessy C; Cartier D; Lectez B; Bucharles C; Chartrel N; Montero-Hadjadje M; Bizet P; Chatenet D; Tostivint H; Scalbert E; Leprince J; Vaudry H; Jégou S; Lihrmann I
J Neurochem; 2008 Oct; 107(2):361-74. PubMed ID: 18710417
[TBL] [Abstract][Full Text] [Related]
9. Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo.
Wu YQ; Song Z; Zhou CH; Xing SH; Pei DS; Zheng JN
Oncol Rep; 2010 Nov; 24(5):1179-84. PubMed ID: 20878108
[TBL] [Abstract][Full Text] [Related]
10. Urotensin II-related peptide, the endogenous ligand for the urotensin II receptor in the rat brain.
Mori M; Fujino M
Peptides; 2004 Oct; 25(10):1815-8. PubMed ID: 15476951
[TBL] [Abstract][Full Text] [Related]
11. Urantide alleviates the symptoms of atherosclerotic rats in vivo and in vitro models through the JAK2/STAT3 signaling pathway.
Wang T; Xie L; Bi H; Li Y; Li Y; Zhao J
Eur J Pharmacol; 2021 Jul; 902():174037. PubMed ID: 33891969
[TBL] [Abstract][Full Text] [Related]
12. The UII/UT system mediates upregulation of proinflammatory cytokines through p38 MAPK and NF-κB pathways in LPS-stimulated Kupffer cells.
Liu LM; Liang DY; Ye CG; Tu WJ; Zhu T
PLoS One; 2015; 10(3):e0121383. PubMed ID: 25803040
[TBL] [Abstract][Full Text] [Related]
13. Development of Novel
Poret B; Desrues L; Bonin MA; Pédard M; Dubois M; Leduc R; Modzelewski R; Decazes P; Morin F; Vera P; Castel H; Bohn P; Gandolfo P
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32204509
[TBL] [Abstract][Full Text] [Related]
14. Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl
Zhang R; Chen J; Liu D; Wang Y
Front Med; 2019 Jun; 13(3):398-408. PubMed ID: 30820806
[TBL] [Abstract][Full Text] [Related]
15. International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to function.
Vaudry H; Leprince J; Chatenet D; Fournier A; Lambert DG; Le Mével JC; Ohlstein EH; Schwertani A; Tostivint H; Vaudry D
Pharmacol Rev; 2015; 67(1):214-58. PubMed ID: 25535277
[TBL] [Abstract][Full Text] [Related]
16. Urotensin II, urotensin-related peptide, and their receptor in aortic valve stenosis.
Khan K; Albanese I; Yu B; Shalal Y; Al-Kindi H; Alaws H; Tardif JC; Gourgas O; Cerutti M; Schwertani A
J Thorac Cardiovasc Surg; 2021 Jan; 161(1):e1-e15. PubMed ID: 31679703
[TBL] [Abstract][Full Text] [Related]
17. Insight into the role of urotensin II-related peptide tyrosine residue in UT activation.
Billard E; Létourneau M; Hébert TE; Chatenet D
Biochem Pharmacol; 2017 Nov; 144():100-107. PubMed ID: 28784291
[TBL] [Abstract][Full Text] [Related]
18. Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury.
Prosser HC; Forster ME; Richards AM; Pemberton CJ
Peptides; 2008 May; 29(5):770-7. PubMed ID: 17900760
[TBL] [Abstract][Full Text] [Related]
19. Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice.
Zhou CH; Wan YY; Chu XH; Song Z; Xing SH; Wu YQ; Yin XX
Oncol Lett; 2012 Dec; 4(6):1259-1263. PubMed ID: 23226801
[TBL] [Abstract][Full Text] [Related]
20. The effects of urotensin II on migration and invasion are mediated by NADPH oxidase-derived reactive oxygen species through the c-Jun N-terminal kinase pathway in human hepatoma cells.
Li YY; Shi ZM; Yu XT; Feng P; Wang XJ
Peptides; 2017 Feb; 88():106-114. PubMed ID: 27988353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
